|
Laurel A. Lagenaur, Ph.D is a Senior Scientist at Osel, and was the Primary Investigator for SBIR Phase I grant in support of the development of the MucoCept HIV approach. Dr. Lagenaur is a molecular biologist, with experience in virology and bacteriology. She received her Ph.D. from Stanford University from the Department of Microbiology and Immunology, on the molecular pathogenesis of murine cytomegalovirus. Dr. Lagenaur completed a three-year postdoctoral fellowship in the Department of Stomatology at the University of California, San Francisco where she studied the pathogenesis of Epstein Barr Virus in HIV disease. In addition, prior to her graduate studies, Dr. Lagenaur has seven years experience as a clinical microbiologist in both human and veterinary fields. | 